VISTAKON® Pharmaceuticals, LLC
World–class expertise and talent–now in ophthalmics
In the coming years, you can expect to see the introduction of many new agents to improve your patients’ ocular health. And you can expect several of them, we are pleased to add, to come from VISTAKON® Pharmaceuticals, LLC.
You can trust VISTAKON® Pharmaceuticals, LLC to discover, develop, and deliver best-in-class treatments for patients with ophthalmic conditions. All with the clinically proven efficacy and safety your patients need.
By dedicating ourselves to this promise today, we will meet our goal of becoming a recognized, worldwide leader in ophthalmics. Not just for ourselves, but for the doctors, nurses, and patients we serve as well.
To help assure our success, we are leveraging the expertise of our sister companies —Johnson & Johnson Pharmaceutical Research & Development, LLC; Ortho-McNeil Pharmaceutical, Inc.; Ortho Biotech Products, LP; Janssen Pharmaceutica Products, LP; Centocor, Inc.; and Scios Inc.— to screen a library of agents for potential topical use in ophthalmics. In addition, we have assembled talented sales and marketing individuals with experience in a multitude of therapeutic areas, including vision care.
Our Medical Affairs Department is here for you.
For more information about our products, or to report a product complaint, call 1.800.523.6225, option 2 and then option 3.
and marketed by VISTAKON® Pharmaceuticals, LLC. 